Evidence map›Paper›PMID 20592220›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy.

Megan S Wyeth, Nianhui Zhang, Istvan Mody, Carolyn R Houser

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Altered Dynamics of Canonical Feedback Inhibition Predicts Increased Burst Transmission in Chronic Epilepsy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Megan S WyethDepartments of Neurobiology and Neurology and Physiology, Brain Research Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA.
Nianhui Zhang
Istvan Mody
Carolyn R Houser
University of California, Los Angeles · USInstitute of Neurobiology · BG

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
SYSTEMS PATHOPHYSIOLOGYP01NS002808 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODY, ISTVAN · 1985 to 2010
$13.5M
ZINC AND GABAA RECEPTOR PLASTICITYP01NS035985 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODY, ISTVAN · 1998 to 2009
$7.9M
GABA Neurons and EpilepsyR01NS046524 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUSER, CAROLYN R · 2003 to 2007
$1.6M
Neuronal Loss and Plasticity in EpilepsyI01BX000404 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HOUSER, CAROLYN R · 2011 to 2013
–
BLRD VA I01 BX000404NIDDK NIH HHS DK41301NIDDK NIH HHS P30 DK041301NINDS NIH HHS NS002808NINDS NIH HHS NS035985NINDS NIH HHS NS046524NINDS NIH HHS P01 NS002808NINDS NIH HHS P01 NS035985NINDS NIH HHS R01 NS046524
6 · The paper itself

Abstract

Perisomatic inhibition from basket cells plays an important role in regulating pyramidal cell output. Two major subclasses of CA1 basket cells can be identified based on their expression of either cholecystokinin (CCK) or parvalbumin. This study examined their fates in the mouse pilocarpine model of temporal lobe epilepsy. Overall, immunohistochemical labeling of GABAergic boutons in the pyramidal cell layer of CA1 was preserved in the mouse model. However, CCK-labeled boutons in this layer were chronically reduced, whereas parvalbumin-containing boutons were conserved. Immunohistochemistry for cannabinoid receptor 1 (CB(1)), another marker for CCK-containing basket cells, also labeled fewer boutons in pilocarpine-treated mice. Hours after status epilepticus, electron microscopy revealed dark degenerating terminals in the pyramidal cell layer with lingering CCK and CB(1) immunoreactivity. In mice with recurrent seizures, carbachol-induced enhancement of spontaneous IPSCs (sIPSCs) originating from CCK-containing basket cells was accordingly reduced in CA1 pyramidal cells. By suppressing sIPSCs from CCK-expressing basket cells, a CB(1) agonist reverted the stimulatory effects of carbachol in naive mice to levels comparable with those observed in cells from epileptic mice. The agatoxin-sensitive component of CA1 pyramidal cell sIPSCs from parvalbumin-containing interneurons was increased in pilocarpine-treated mice, and miniature IPSCs were reduced, paralleling the decrease in CCK-labeled terminals. Altogether, the findings are consistent with selective reduction in perisomatic CA1 pyramidal cell innervation from CCK-expressing basket cells in mice with spontaneous seizures and a greater reliance on persisting parvalbumin innervation. This differential alteration in inhibition may contribute to the vulnerability of the network to seizure activity.

Indexed as

AnimalsCA1 Region, HippocampalCholecystokininDisease Models, AnimalEpilepsy, Temporal Lobegamma-Aminobutyric AcidInhibitory Postsynaptic PotentialsMaleMiceNeural PathwaysNeuronsParvalbuminsPilocarpinePresynaptic TerminalsPyramidal CellsReceptor, Cannabinoid, CB1Cholecystokiningamma-Aminobutyric AcidParvalbuminsPilocarpineReceptor, Cannabinoid, CB1

Identifiers

PMID20592220
PMCPMC3319326
OpenAlexW2011747330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.